David M. Stark - 03 Mar 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: Exec. VP Chief Legal Officer
Signature: /s/ Dov Bergwerk as attorney-in-fact for David M. Stark
Issuer symbol: TEVA
Transactions as of: 03 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 07 Mar 2023, 15:14:08 UTC
Previous filing: 02 Mar 2023
Next filing: 08 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TEVA	Ordinary Shares	Options Exercise		+13,931	+468%		16,905	04 Mar 2023	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+31,836	+188%		48,741	04 Mar 2023	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+20,199	+41%		68,940	05 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TEVA	Restricted Share Units	Award	$0	+94,621		$0.000000	94,621	03 Mar 2023	Ordinary Shares	94,621		Direct	F1, F2, F3
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-13,931	-100%	$0.000000^*	0	04 Mar 2023	Ordinary Shares	13,931		Direct	F1, F2, F4
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-31,836	-25%	$0.000000	95,509	04 Mar 2023	Ordinary Shares	31,836		Direct	F1, F2, F5
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-20,199	-33%	$0.000000	40,400	05 Mar 2023	Ordinary Shares	20,199		Direct	F1, F2, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3	Restricted share units were granted on March 3, 2023, with 23,655 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 23,656 vesting on March 3, 2027.
F4	Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
F5	Restricted share units were granted on March 4, 2022, with 31,836 vested on March 4, 2023, 31,836 vesting on each of March 4, 2024 and March 4, 2025 and 31,837 vesting on March 4, 2026.
F6	Restricted share units were granted on March 5, 2021, with 20,199 vested on each of March 5, 2022 and March 5, 2023, 20,199 vesting on March 5, 2024, and 20,201 vesting on March 5, 2025.